AG001HZM

142217-77-4 | Cyclopentanol, 5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-

Chemical structure of Cyclopentanol, 5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-, CAS 142217-77-4
AG001HZM
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 142217-77-4
Catalog Number AG001HZM(AGN-PC-0PS0LH)
Chemical Name Cyclopentanol, 5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-
IUPAC Name (1S,2S,3S,5S)-5-(2-amino-6-phenylmethoxypurin-9-yl)-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol
InChI InChI=1S/C32H33N5O4/c33-32-35-30-28(31(36-32)41-19-24-14-8-3-9-15-24)34-21-37(30)26-16-27(40-18-23-12-6-2-7-13-23)25(29(26)38)20-39-17-22-10-4-1-5-11-22/h1-15,21,25-27,29,38H,16-20H2,(H2,33,35,36)/t25-,26+,27+,29+/m1/s1
InChI Key SYPCZZWUNIHLBU-COROXYKFSA-N
MDL Number MFCD09750977
Molecular Formula C32H33N5O4
Molecular Weight 551.6355
SMILES O[C@H]1[C@H](COCC2=CC=CC=C2)[C@@H](OCC3=CC=CC=C3)C[C@@H]1N4C=NC5=C(OCC6=CC=CC=C6)N=C(N)N=C45
Synonyms
142217-77-4, (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol, Entecavir Intermediate IV, Cyclopentanol, 5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-, W-205568, (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cydopentanol, (1S,2S,3S,5S)-5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-Cyclopentanol, entecavir-4, AK-33259, n-1-ol, CYC088, CYC089, SCHEMBL2519691, CTK8B4566, DTXSID90672073, C32H33N5O4, BCP21001, ANW-45489, CE0038, RW2435, AKOS015896664, ZINC100008388, AC-5919, AM84384, AN-10512, DS-12112, TC-134234, R3-04, ST24026089, W3096, 217A774, A807869, I06-2208, (1S,2S,3S,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopenta, (1s,2s,3s,5s)-5-(2-amino-6-(benzyloxy)-9h-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopenta, (1S,2S,3S,5S)-5-(2-amino-6-benzyloxy-purin-9-yl)-3-benzyloxy-2-(benzyloxymethyl)cyclopentanol, (1S,2S,3S,5S)-5-(2-amino-6-phenylmethoxy-9-purinyl)-3-phenylmethoxy-2-(phenylmethoxymethyl)-1-cyclopentanol, (1S,2S,3S,5S)-5-(2-azanyl-6-phenylmethoxy-purin-9-yl)-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol, (1S,2S,3S,5S)-5-[2-Amino-6-(benzyloxy)-9H-purin-9-yl]-3-(benzyloxy)-2-[(benzyloxy)methyl]cyclopentan-1-ol, Entecavir intermediates D, SYPCZZWUNIHLBU-COROXYKFSA-N, ACN-039762, (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benz yloxy)-2-(benzyloxymethyl)cyclopentanol, (1S,2S,3S,5S)-5-(2-amino-6-phenylmethoxypurin-9-yl)-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited